Hôpital Femme-Mère-Enfant des Hospices Civils de Lyon
Bron, 69677, France
NCT Number: NCT05070975
Respiratory syncytial virus (RSV) infection is the most common cause of severe lower respiratory tract infection (LRTI) in the pediatric population worldwide. Age at the time of infection, prematurity, multiparity, exposure to smoke and the level of passive immunity transmitted at birth are the main risk factors for lower respiratory infection associated with RSV. Other factors, including the innate immune response, respiratory microbiota, and intra-host viral heterogeneity, may also affect outcomes but are not fully considered in RSV infection. Exploring the impact of these factors is difficult due to the heterogeneity of the population which makes statistical adjustment difficult. Thus, twin models are useful in understanding the impact of the host on the environment, as twins often share similar exposure to infection and many risk factors, but not all are ie different prenatal and postnatal conditions, differential transfer of maternal antibodies and the genetic makeup of heterozygotes.
Looking for future studies?
Notify MeUp to 354 day
All sexes
Observational
Bron, 69677, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment of the discrepancy of clinical severity of RSV-infections between twin infants.
Time frame: 1 day
The primary outcome measure is the percentage of discordant twin pairs of at least one severity level on the WHO (World Health Organization) scale.
The discrepancy in the level of severity is obtained by retrospective analysis of the data from the medical file.
Hospices Civils de Lyon
Other
Phenotype Severity of RSV-infections in Twins During the First Year of Life
Acronym: TwinSeVeRS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03062917
Bronchial Diseases, Bronchiolitis
London, United Kingdom
View Trial DetailsNCT01090557
Bronchial Diseases, Bronchiolitis
Mineola, New York, United States
View Trial DetailsNCT05765396
COVID-19, COVID-19 Pneumonia
Fort Sam Houston, Texas, United States
View Trial DetailsNCT04944160
Asthma, Bronchial Diseases
Bron, France
View Trial Details